Evidence map›Paper›PMID 22852066›Full record

ReviewToxins2012

Bacillus anthracis edema factor substrate specificity: evidence for new modes of action.

Martin Göttle, Stefan Dove, Roland Seifert

Open access · goldAbstract readReview
In one paragraph

Review in Toxins, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

Martin GöttleDepartment of Neurology, Emory University School of Medicine, Atlanta, GA 30322, USA. Mgoettl@emory.edu
Stefan Dove
Roland Seifert
Medizinische Hochschule Hannover · DEUniversity of Regensburg · DEWoodruff Health Sciences Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since the isolation of Bacillus anthracis exotoxins in the 1960s, the detrimental activity of edema factor (EF) was considered as adenylyl cyclase activity only. Yet the catalytic site of EF was recently shown to accomplish cyclization of cytidine 5'-triphosphate, uridine 5'-triphosphate and inosine 5'-triphosphate, in addition to adenosine 5'-triphosphate. This review discusses the broad EF substrate specificity and possible implications of intracellular accumulation of cyclic cytidine 3':5'-monophosphate, cyclic uridine 3':5'-monophosphate and cyclic inosine 3':5'-monophosphate on cellular functions vital for host defense. In particular, cAMP-independent mechanisms of action of EF on host cell signaling via protein kinase A, protein kinase G, phosphodiesterases and CNG channels are discussed.

Indexed as

3',5'-Cyclic-AMP PhosphodiesterasesAdenylyl CyclasesAnimalsAntigens, BacterialBacillus anthracisBacterial ToxinsCatalytic DomainExotoxinsHumansModels, MolecularNucleotides, CyclicProtein ConformationSignal TransductionSubstrate SpecificityUridine Monophosphate3',5'-Cyclic-AMP PhosphodiesterasesAdenylyl Cyclasesanthrax toxinAntigens, BacterialBacterial Toxinscyclic 3',5'-uridine monophosphateExotoxinsNucleotides, CyclicUridine Monophosphateadenylyl cyclase toxinanthraxBacillus anthracisedema factoredema toxin

Identifiers

PMID22852066
PMCPMC3407890
OpenAlexW2165688324

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.